Viking Therapeutics (VKTX) EPS (Diluted) (2017 - 2026)

Viking Therapeutics (VKTX) EPS (Diluted) (2017 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 0.00
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.15
4 NuCana 279.75 Bn 279.75 Bn - -368,323.02
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 4.02
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 6.75
7 Belite Bio 62.51 Bn 62.51 Bn - 0.00
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 7.33
9 Revolution Medicines 37.78 Bn 37.78 Bn - -2.29
10 Viking Therapeutics 4.09 Bn 4.09 Bn - -2.30

Historic Data

Download Data
DateValue
Mar 31, 2026 -2.30
Dec 31, 2025 -2.47
Sep 30, 2025 -1.54
Jun 30, 2025 -1.35
Mar 31, 2025 -1.08
Dec 31, 2024 -1.74
Sep 30, 2024 -2.60
Jun 30, 2024 -2.33
Mar 31, 2024 -4.22
Dec 31, 2023 -0.97
Sep 30, 2023 -233.95
Jun 30, 2023 -501.13
Mar 31, 2023 -770.20
Dec 31, 2022 -0.52
Sep 30, 2022 -0.23
Jun 30, 2022 -0.25
Mar 31, 2022 -0.24
Dec 31, 2021 -0.20
Sep 30, 2021 -0.24
Jun 30, 2021 -0.26